🇺🇸 Antidepressant Therapy in United States
10 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 10
Most-reported reactions
- Abnormal Behaviour — 1 report (10%)
- Death — 1 report (10%)
- Depression — 1 report (10%)
- Drug Ineffective — 1 report (10%)
- Drug Interaction — 1 report (10%)
- Inappropriate Schedule Of Drug Administration — 1 report (10%)
- Nervousness — 1 report (10%)
- Paranoia — 1 report (10%)
- Serotonin Syndrome — 1 report (10%)
- Therapeutic Product Ineffective — 1 report (10%)
Other Psychiatry / Mental Health approved in United States
Frequently asked questions
Is Antidepressant Therapy approved in United States?
Antidepressant Therapy does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Antidepressant Therapy in United States?
RAND is the originator. The local marketing authorisation holder may differ — check the official source linked above.